TAI is a biotechnology company that focuses on providing a non-invasive and sensitive diagnostic test to monitor the health of transplanted organs... Read more
TAI is a biotechnology company that focuses on providing a non-invasive and sensitive diagnostic test to monitor the health of transplanted organs... Read more
News
Jan 14, 2020
Silicon Valley Daily
TAI Diagnostics: TAI Diagnostics Announces Publication of Analytical and Clinical Validation Studies Supporting Use of the myTAI-HEART Test for Non-Invasive Post-Transplant Assessment of Rejection Probability in Adult and Pediatric Heart Transplant Patients
Dec 18, 2019
Silicon Valley Daily
TAI Diagnostics: Clinical Study Utilizes the myTAIHEART Test to Monitor Cell-Free DNA Levels, 2-10 Days Post-Transplantation, in Pediatric Heart Transplant Recipients
Dec 13, 2019
BioPortfolio
TAI Diagnostics: ÂNIHNHLBI Clinical Study Reports on Donor Fraction CellFree DNA Analysis as an Indicator of Heart Transplant Rejection in Adult and Pediatric Patients
Oct 31, 2019
WorldNews
TAI Diagnostics: myTAIHEART Test Provides Evidence for Injury from Biopsy of Heart Transplant Recipients
Jun 05, 2019
BizTimes
TAI Diagnostics: TAI Diagnostics launches series B funding round
May 27, 2019
BizTimes
TAI Diagnostics: TAI Diagnostics Inc.
Jul 03, 2018
BizTimes
TAI Diagnostics: TAI Diagnostics raises more than expected
Jul 02, 2018
BioPortfolio
TAI Diagnostics: Fresh Off Launch of First Test TAI Diagnostics Adds Funding
Jun 29, 2018
The Business Journals: Greensboro/Winston-Salem/High Point
TAI Diagnostics: Tai Diagnostics of Tosa investing up to $13M in clinical trials, product development
Jan 17, 2018
Journal Sentinel
TAI Diagnostics: TAI Diagnostics raises another $10 million in funding for transplant test